Anti-COVID Drug Developed By DRDO For Emergency Use Gets DCGI’s Nod
New Delhi: An anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in…